{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:44:31Z","timestamp":1774680271614,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria in pregnancy causes adverse effects on the mother and fetus, requiring effective antimalarial treatment. Understanding the transplacental transfer of antimalarials is vital to assessing fetal safety and the risk of congenital malaria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed a triad of blood samples (mother and neonatal capillary, cord) at delivery among women who were treated for uncomplicated malaria with artemether\u2013lumefantrine (AL), artesunate\u2013mefloquine (ASMQ), or dihydroartemisinin\u2013piperaquine (DP) 4\u20138 weeks before delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Antimalarial drug concentrations at delivery were measured in 90 women (25 AL, 29 ASMQ, 36 DP). Drug concentrations were detectable in neonates at birth at a maximum of 27, 42, and 55 days after the first dose of lumefantrine, mefloquine, and piperaquine, respectively. The blood concentrations were highest in the mother, followed by the neonate, and lowest in cord blood. Piperaquine showed the highest neonate-to-mother (N\/M) ratio (geometric mean, 0.98; 95% confidence interval, 0.67\u20131.44; n = 32) followed by carboxy\u2013mefloquine (0.90; 0.75\u20131.08; n = 27), desbutyl\u2013lumefantrine (0.44; 0.30\u20130.65; n = 16), mefloquine (0.42; 0.38\u20130.47; n = 26), and lumefantrine (0.31; 0.07\u20131.36; n = 9). Higher maternal body mass index was associated with a lower N\/M ratio of desbutyl\u2013lumefantrine. Female neonatal sex and a longer interval following drug administration were associated with higher N\/M ratios of carboxy\u2013mefloquine. No increased risk of jaundice was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Antimalarial drugs crossed the placenta variably. Neonatal concentrations ranged from less than half (lumefantrine, mefloquine) to near maternal equivalence (piperaquine). Collection of neonatal capillary samples at birth should be considered in future studies.<\/jats:p>\n                    <jats:p>Summary<\/jats:p>\n                    <jats:p>We compared antimalarial blood concentrations in mothers, neonates, and cords. Neonatal drug concentrations ranged from near maternal equivalence (piperaquine) to less than half (lumefantrine, mefloquine). Cord concentrations may underestimate neonatal exposure. Future studies should consider neonatal capillary sampling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf552","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:02:39Z","timestamp":1759406559000},"page":"e165-e173","source":"Crossref","is-referenced-by-count":3,"title":["Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-9287","authenticated-orcid":false,"given":"Makoto","family":"Saito","sequence":"first","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]},{"name":"Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-8123","authenticated-orcid":false,"given":"Mary Ellen","family":"Gilder","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena Ilona","family":"Carrara","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]},{"name":"Faculty of Medicine, Institute of Global Health, University of Geneva , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laypaw","family":"Archusuksan","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsa","family":"Eh","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naw","family":"Eh","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Ner","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aye Kyi","family":"Win","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laaongsri","family":"Niwetphongprai","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urairat","family":"Koesukwiwat","sequence":"additional","affiliation":[{"name":"Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-4030","authenticated-orcid":false,"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]},{"name":"Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":false,"given":"Nicholas J","family":"White","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]},{"name":"Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Bangkok ,","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-3257","authenticated-orcid":false,"given":"Rose","family":"McGready","sequence":"additional","affiliation":[{"name":"Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University , Mae Ramat ,","place":["Thailand"]},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2026020904073966600_ciaf552-B1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2352-4642(20)30099-7","article-title":"Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs","volume":"4","author":"Saito","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2026020904073966600_ciaf552-B2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.placenta.2003.10.019","article-title":"The sick placenta\u2014the role of malaria","volume":"25","author":"Brabin","year":"2004","journal-title":"Placenta"},{"key":"2026020904073966600_ciaf552-B3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.placenta.2004.09.006","article-title":"Human placenta: a human organ for developmental toxicology research and biomonitoring","volume":"26","author":"Myllynen","year":"2005","journal-title":"Placenta"},{"key":"2026020904073966600_ciaf552-B4","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/jcph.1491","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"2026020904073966600_ciaf552-B5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/505150","article-title":"Umbilical cord\u2013blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya","volume":"194","author":"Malhotra","year":"2006","journal-title":"J Infect Dis"},{"key":"2026020904073966600_ciaf552-B6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejogrb.2020.06.025","article-title":"Global prevalence of congenital malaria: a systematic review and meta-analysis","volume":"252","author":"Bilal","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026020904073966600_ciaf552-B7","doi-asserted-by":"crossref","first-page":"20859","DOI":"10.1038\/srep20859","article-title":"Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting","volume":"6","author":"Charnaud","year":"2016","journal-title":"Sci Rep"},{"key":"2026020904073966600_ciaf552-B8","doi-asserted-by":"crossref","first-page":"e7986","DOI":"10.1371\/journal.pone.0007986","article-title":"Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model","volume":"4","author":"May","year":"2009","journal-title":"PLoS One"},{"key":"2026020904073966600_ciaf552-B9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1381612825666190320162507","article-title":"Pharmacokinetics, placental and breast milk transfer of antiretroviral drugs in pregnant and lactating women living with HIV","volume":"25","author":"Hodel","year":"2019","journal-title":"Curr Pharm Des"},{"key":"2026020904073966600_ciaf552-B10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12916-021-02002-8","article-title":"A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border","volume":"19","author":"Saito","year":"2021","journal-title":"BMC Med"},{"key":"2026020904073966600_ciaf552-B11","doi-asserted-by":"crossref","first-page":"e0009324","DOI":"10.1128\/aac.00093-24","article-title":"Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria","volume":"68","author":"Saito","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020904073966600_ciaf552-B12","doi-asserted-by":"crossref","first-page":"e02473-20","DOI":"10.1128\/AAC.02473-20","article-title":"Randomized controlled trial of the electrocardiographic effects of four antimalarials for pregnant women with uncomplicated malaria on the Thailand-Myanmar border","volume":"65","author":"Saito","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020904073966600_ciaf552-B13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jchromb.2005.06.022","article-title":"High throughput assay for the determination of lumefantrine in plasma","volume":"822","author":"Annerberg","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2026020904073966600_ciaf552-B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jchromb.2007.12.011","article-title":"Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects","volume":"862","author":"Lindegardh","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2026020904073966600_ciaf552-B15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-199528050-00001","article-title":"Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations","volume":"28","author":"Ward","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"2026020904073966600_ciaf552-B16","doi-asserted-by":"crossref","first-page":"1111601","DOI":"10.3389\/fphar.2023.1111601","article-title":"Drug exposure during pregnancy: current understanding and approaches to measure maternal-fetal drug exposure","volume":"14","author":"Hudson","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026020904073966600_ciaf552-B17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","article-title":"Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals","volume":"53","author":"McCormack","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"2026020904073966600_ciaf552-B18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2125.2008.03111.x","article-title":"Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers","volume":"65","author":"Law","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2026020904073966600_ciaf552-B19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3565(25)38693-3","article-title":"Mefloquine transfer during in vitro human placenta perfusion","volume":"269","author":"Barzago","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020904073966600_ciaf552-B20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(22)01881-5","article-title":"Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis","volume":"401","author":"Saito","year":"2023","journal-title":"Lancet"},{"key":"2026020904073966600_ciaf552-B21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clinl Pharmacol Ther"},{"key":"2026020904073966600_ciaf552-B22","first-page":"1","volume-title":"Encyclopedia of malaria","author":"Na-Bangchang","year":"2019"},{"key":"2026020904073966600_ciaf552-B23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"2026020904073966600_ciaf552-B24","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.00708-06","article-title":"Role of P glycoprotein in absorption of novel antimalarial drugs","volume":"50","author":"Crowe","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020904073966600_ciaf552-B25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/AAC.01382-13","article-title":"Investigation of the functional role of P-glycoprotein in limiting the oral bioavailability of lumefantrine","volume":"58","author":"Wahajuddin","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020904073966600_ciaf552-B26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4269\/ajtmh.2012.11-0817","article-title":"Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells","volume":"87","author":"Oga","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"2026020904073966600_ciaf552-B27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0006-2952(96)00556-4","article-title":"Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine","volume":"52","author":"Riffkin","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"2026020904073966600_ciaf552-B28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bcp.2005.05.022","article-title":"Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes","volume":"70","author":"Wu","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"2026020904073966600_ciaf552-B29","doi-asserted-by":"crossref","first-page":"e0152677","DOI":"10.1371\/journal.pone.0152677","article-title":"The interactions of P-glycoprotein with antimalarial drugs, including substrate affinity, inhibition and regulation","volume":"11","author":"Senarathna","year":"2016","journal-title":"PLoS One"},{"key":"2026020904073966600_ciaf552-B30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.04140-14","article-title":"Carboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor","volume":"59","author":"Piedade","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020904073966600_ciaf552-B31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/dmd.110.034983","article-title":"Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice","volume":"39","author":"Gahir","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"2026020904073966600_ciaf552-B32","doi-asserted-by":"crossref","first-page":"115137","DOI":"10.1016\/j.taap.2020.115137","article-title":"Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure","volume":"406","author":"Xiang","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026020904073966600_ciaf552-B33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"2026020904073966600_ciaf552-B34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.placenta.2020.07.009","article-title":"Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues","volume":"100","author":"Robinson","year":"2020","journal-title":"Placenta"},{"key":"2026020904073966600_ciaf552-B35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1203\/00006450-197502000-00009","article-title":"Placental transfer and fetal urinary excretion of gentamicin during constant rate maternal infusion","volume":"9","author":"Kauffman","year":"1975","journal-title":"Pediatr Res"},{"key":"2026020904073966600_ciaf552-B36","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/QAD.0b013e32833d8a50","article-title":"High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women","volume":"24","author":"McKeown","year":"2010","journal-title":"AIDS"},{"key":"2026020904073966600_ciaf552-B37","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1097\/QAD.0b013e32835a9aeb","article-title":"Raltegravir in the prevention of mother-to-child transmission of HIV-1: effective transplacental transfer and delayed plasma clearance observed in preterm neonates","volume":"26","author":"Hegazi","year":"2012","journal-title":"AIDS"},{"key":"2026020904073966600_ciaf552-B38","doi-asserted-by":"crossref","first-page":"114059","DOI":"10.1016\/j.jpeds.2024.114059","article-title":"Umbilical cord blood as an alternative to neonatal blood for complete blood count: a comparison study","volume":"271","author":"Heeger","year":"2024","journal-title":"J Pediatr"},{"key":"2026020904073966600_ciaf552-B39","doi-asserted-by":"crossref","first-page":"e0000475","DOI":"10.1371\/journal.pgph.0000475","article-title":"Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border","volume":"2","author":"Bancone","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"2026020904073966600_ciaf552-B40","doi-asserted-by":"crossref","first-page":"e008686","DOI":"10.1161\/CIRCEP.120.008686","article-title":"Electrocardiographic QT intervals in infants exposed to hydroxychloroquine throughout gestation","volume":"13","author":"Friedman","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026020904073966600_ciaf552-B41","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.00955-07","article-title":"Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand","volume":"52","author":"Tarning","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf552\/65117251\/ciaf552.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/e165\/65117251\/ciaf552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/1\/e165\/65117251\/ciaf552.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:07:50Z","timestamp":1770628070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/1\/e165\/8313131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,4]]},"published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf552","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,15]]},"published":{"date-parts":[[2025,11,4]]}}}